| http://www.w3.org/ns/prov#value | - Given that IGF-1 is a growth factor and the effect of prolonged elevations in IGF-1 levels on the development or progression of malignancies is unknown, IGF-1 levels should be monitored closely during EGRIFTA??? (tesamorelin for injection) therapy.
|
